Sustained release glucocorticoid pharmaceutical composition

Details Sustained release glucocorticoid pharmaceutical composition Sustained release glucocorticoid pharmaceutical composition

1996-12-19

1998-08-11

Page, Thurman K.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

424489, A61K 920

Patent

active

057924767

ABSTRACT:
A pharmaceutical composition for peroral treatment of rheumatoid arthritis and a treatment method therefor are described, wherein said composition comprises 2.5-7 mg of a glucocorticoid as active substance with a regulated sustained release such that at least 90% by weight of the glucocorticoid is released during a period of about 40-80 min, starting about 1-3 h after the entry of said glucocorticoid into the small intestine of a mammal.

REFERENCES:
patent: 5019562 (1991-05-01), Folkman et al.
patent: 5128320 (1992-07-01), Hahn et al.
patent: 5449515 (1995-09-01), Hamilton et al.
"Time of Day Medicine Dose is Taken May Boost its Efficacy, Cut Toxicity," Medical News & Perspectives, JAMA, Apr. 17, 1996, vol. 275, No. 15, pp. 1143-1144.
Abstract of EP-656204.
Abstract of AU 9463426.
Abstract of JP 06256166.
Abstract of US 5,288,503.
Abstract of WO 9621448.
Abstract of US 5,536,507.
Abstract of WO 9611674.
Abstract of WO 9610397.
Abstract WO 9528916.
Abstract of US 5,541,171.
Abstract of JP 06-336444.
Abstract of US 5,160,744.
Abstract of EP 605174.
Abstract of US 5,178,867.
Abstract of US 5,102,668.
Abstract of US 4,863,742.
Abstract of EP 250267.
Abstract of EP 366868.

Affiliated with

Also associated with

Rating

Sustained release glucocorticoid pharmaceutical composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sustained release glucocorticoid pharmaceutical composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release glucocorticoid pharmaceutical composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-386703